NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
+ Phase 3 data due June 2020 -> Signal for the Bull.
評論:
+ Reset near $533.64 and long target will be $605.88 (ATH)
+ Just my idea, use as reference. Not an advice
評論:
Hit $533.64, will hold support. Looking for further movement. Congrats whoever follow the plan
評論:
Hell yeah my baby
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。